BFA
FPRX

BlackRock Fund Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

BlackRock Fund Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$61M Buy
1,217,898
+137,655
+13% +$7.23M 0.01% 1550
2016
Q3 		$56.7M Buy
1,080,243
+71,528
+7% +$3.42M 0.01% 1488
2016
Q2 		$41.7M Buy
1,008,715
+64,281
+7% +$2.8M 0.01% 1611
2016
Q1 		$38.4M Buy
944,434
+15,566
+2% +$535K 0.01% 1607
2015
Q4 		$38.5M Sell
928,868
-4,806
-0.5% -$161K 0.01% 1655
2015
Q3 		$14.4M Buy
933,674
+36,189
+4% +$778K ﹤0.01% 2199
2015
Q2 		$22.3M Buy
897,485
+11,247
+1% +$251K 0.01% 2044
2015
Q1 		$20.3M Buy
886,238
+156,746
+21% +$3.96M ﹤0.01% 2060
2014
Q4 		$19.7M Buy
729,492
+316,886
+77% +$5.45M ﹤0.01% 2075
2014
Q3 		$4.84M Sell
412,606
-10,816
-3% -$136K ﹤0.01% 2774
2014
Q2 		$6.58M Buy
423,422
+231,131
+120% +$3.31M ﹤0.01% 2672
2014
Q1 		$3.78M Buy
192,291
+42,598
+28% +$723K ﹤0.01% 2970
2013
Q4 		$2.51M Buy
+149,693
New +$1.86M ﹤0.01% 3107

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock Fund Advisors's FPRX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Five Prime Therapeutics, Inc. (FPRX) stake by 13% in Q4 2016, buying an estimated $7.23M and bringing the position to 1,217,898 shares worth $61M. The position accounts for 0.01% of the portfolio, ranked #1550.

BlackRock Fund Advisors first reported a position in FPRX in Q4 2013 and has held it in 13 quarters since. 172 funds tracked by Wall St. Rank hold FPRX as of Q4 2016.

  • BlackRock Fund Advisors held 1,217,898 shares of Five Prime Therapeutics, Inc. worth $61M as of Q4 2016.
  • BlackRock Fund Advisors bought 137,655 Five Prime Therapeutics, Inc. shares in Q4 2016, an estimated $7.23M.
  • Five Prime Therapeutics, Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1550 holding.
  • BlackRock Fund Advisors first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and has held it in 13 quarters since.
  • 172 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.